Upregulation of Key Molecules for Targeted Imaging and Therapy

Abstract

We present an approach that uses epigenetic modifiers to improve sstr₂ targeting in vitro and in vivo. Translation of this method into the clinic may potentially convert patients ineligible for targeted imaging and therapy to eligible candidates.